Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

By Di Pierro F, et al. Published June 24, 2021 in the International Journal of General Medicine Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential...

read more
Another Winter of COVID

Another Winter of COVID

Nationwide, the Delta wave is waning, but what do the coming months hold? By Dhruv Khullar, a contributing writer at The New Yorker, is a practicing physician and an assistant professor at Weill Cornell Medical College. The coronavirus pandemic in the United States...

read more